Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 Highest Paying Countries for Pharmacists

In this article, we will look at the 15 highest-paying countries for pharmacists. We have also analyzed the pharmacy industry along with its key market players. If you want to skip our detailed analysis, head straight to the 5 Highest Paying Countries for Pharmacists

The global Pharmacy Benefit Management (PBM) market was valued at $513.98 billion in 2022, and it is expected to reach $809.79 billion by 2030, with a projected CAGR of 6.0% from 2023 to 2030. This growth can be attributed to the rise of chronic diseases, increasing costs of drugs, and skyrocketing demand for specialty drugs. 

Moreover, the rise of telemedicine and remote work in the pharmacy industry has become the new norm. The increasing influence of telemedicine and telehealth services has created a demand for remote pharmacy consultations and prescription order entry. This rise has been accelerated by the COVID-19 pandemic which highlighted the importance of remote healthcare access. 

There is no doubt that internet penetration and the growing number of internet users have a pertinent role in facilitating telepharmacy services. Access to the internet allows patients to connect with pharmacists virtually and enables consultations and prescription fulfillment from the comfort of their homes. Moreover, telepharmacy offers cost savings and operational efficiencies for healthcare providers. This also explains why telemedicine has become one of the best work-from-jobs for 2023

Speaking of cost savings, to address the high pharmaceutical costs, CVS Health Corp (NYSE:CVS) Caremark has launched Caremark Cost Saver, a program in partnership with GoodRx Holdings Inc (NASDAQ:GDRX), with an aim to reduce pharmacy out-of-pocket expenses. This initiative benefits CVS Caremark’s eligible members as it automatically grants them access to GoodRx Holdings Inc (NASDAQ:GDRX)’s prescription pricing for lower-cost general medications.

Patients using this service can save on their drug costs at the pharmacy counter. The amount saved is applied towards members’ deductibles and out-of-pocket limits. No action is required from plan members which further simplifies the process for tens of millions of Americans served by CVS Health Corp (NYSE:CVS) Caremark.

It is also worth noting that CVS Health Corp (NYSE:CVS) has been trying to position itself at the forefront of healthcare transformation as they are cutting approximately 5,000 corporate-level jobs. They have done so to shift their focus and spending towards healthcare by focusing on its stores, pharmacies, and clinics.

This move was followed by CVS Health Corp (NYSE:CVS)’s acquisition of primary care provider Oak Street Health for $10.6 billion and its earlier acquisition of Signify Health for $8 billion, as the company continued to expand into the healthcare sector.

On the financial end, CVS Health Corp (NYSE:CVS) reported its first-quarter results, with earnings per share of $2.20, even though the expectation was $2.09, and revenue of $85.28 billion, compared to an expected $80.81 billion. However, their Q1 profit was $2.14 billion, down from $2.35 billion a year earlier. They attributed the decrease to costs related to their recent acquisitions. 

ClearBridge Value Equity Strategy made the following comment about CVS Health Corporation (NYSE:CVS) in its first quarter 2023 investor letter:

“At the same time, we exited health insurance company Cigna, whose strong outperformance over the last year has resulted in shares trading at a significant premium relative to competitor CVS Health Corporation (NYSE:CVS). Additionally, we view CVS Health’s underperformance as driven by temporary issues and believe it has a good likelihood of succeeding in its improvement initiatives following upgrades to the management team and its acquisition of Oak Street Health. As a result, we elected to swap our position in Cigna into CVS Health to capitalize on the valuation gap while maintaining similar exposure within the sector.”

On the other hand, GoodRx Holdings Inc (NASDAQ:GDRX) is offering savings on antivirals, medications, and vaccines for the upcoming cold and flu season. Last flu season in 2022, the CDC reported over 27 million illnesses, 300,000 hospitalizations, and 19,000 deaths of influenza. GoodRx Holdings Inc (NASDAQ:GDRX) aims to make flu shots more accessible as they are collaborating with Walgreen Company, Walmart Inc (NYSE:WMT), and Weis Markets Inc (NYSE:WMK) to provide flat-rate pricing for flu shots. Prices are under $40 for ages 6 months to 64 years and under $70 for those 65 and older. GoodRx Holdings Inc (NASDAQ:GDRX) also facilitates access to antivirals and medications for flu treatment by advising annual flu shots and potentially separate administration of the RSV vaccine for optimal protection during the tripledemic of flu, COVID-19, and RSV. 

Owing to their exceptional pricing strategies, here is what Saga Partners has to say about GoodRx Holdings, Inc. (NASDAQ:GDRX) in its Q2 2022 investor letter:

“The Portfolio first bought GoodRx at the end of 2020. I discussed the initial thesis in the H1’21 Investor Letter explaining how GoodRx is a prescription marketplace. GoodRx aggregates all available prescription prices across pharmacy benefit managers (PBMs). PBMs are the companies that negotiate prescription pricing with pharmacies on behalf of their insured customers. Historically, uninsured patients had to pay excessively high retail cash prices for prescriptions as a consequence of the contracts between pharmacies and PBMs. Through a discount card provider like GoodRx, consumers could get a coupon to access the much lower PBM prices. PBMs benefitted from discount cards generating incremental demand and earning the administration fees paid by pharmacies. PBMs then shared part of their administration fee with GoodRx.

As the prescription discount card space developed, GoodRx established itself as the dominant company with the second largest company (SingleCare) being about quarter of its size. Part of GoodRx’s success was their patent that enables only them to contract with multiple PBMs on a single interface. This meant that it was likely that the lowest prescription prices for people not using insurance were likely to be found on GoodRx, attracting more customers to GoodRx’s platform, which further incentivized PBMs to offer even lower prices on GoodRx to win that demand…” (Click here to see the full text)”

Methodology

To list the highest-paying countries for pharmacists, we identified the countries with the highest demand for pharmacists and then made a list for 23 countries with the average salaries for pharmacists. Of those 23, the 15 with the highest average salaries were selected and have been ranked. We acquired the data for the average salaries of pharmacists for each country from ERI Economic Research Institute. The list is presented in ascending order.

Here is a list of the highest-paying countries for pharmacists.

15. France

Average Salary: $78,395

To practice in France as a pharmacist, individuals must be registered with the Chamber of Pharmacists and meet strict qualifications requirements, competence, and ethical standards. While pharmacists must complete a six-year PharmD program, they also have plenty of options for post-graduate specialties like clinical practice or laboratory medicine. France is one of the highest-paying countries for pharmacists

14. Germany

Average Salary: $85,197

To practice as a foreign pharmacist in Germany, you need to obtain approval, known as “approbation,” from the competent authorities in the respective German state. This process involves submitting your qualifications for evaluation, language proficiency, and passing a knowledge test. The specific requirements may vary by state. Germany is also one of the highest paying countries for cyber security experts

13. Netherlands

Average Salary: $86,860

To work as a pharmacist in the Netherlands, one must meet specific requirements like fluency in Dutch is essential, as pharmacists have to work with Dutch-speaking patients. They also need a recognized pharmacy degree, which may require sending one’s foreign diploma for evaluation. Then, passing the AKV test, assessing the degree, and obtaining a Declaration of Professional Competence are following necessary steps. Additionally, one also needs a job offer from a Dutch employer to apply for a work permit. The entire process can vary in duration but typically takes several months to complete. Pharmacist salaries in the Netherlands vary based on qualifications and experience. However, generally, it is one of the top-paying countries for pharmacists in the world.

12. Austria

Average Salary: $87,433

Austria had a pharmaceutical market estimated at $9.2 billion in 2021, with 15% of total healthcare spending directed towards pharmaceuticals. The country’s pharmaceutical industry is led by companies like Boehringer Ingelheim Group, Novartis AG (NYSE:NVS), and Pfizer Inc (NYSE:PFE). With over $14 billion in pharmaceutical exports in 2020 and growing domestic production, Austria offers pharmacists a promising career pathway. Its healthcare system, which covers 99% of the population, ensures stability for the sector and hence, promising employment opportunities for pharmacists. Austria is one of the highest-paying countries for pharmacists. 

11. Norway

Average Salary: $90,610

To practice as a pharmacist in Norway, you need a bachelor’s or master’s degree in Pharmacy, equivalent to Norwegian standards. After obtaining your degree, you must apply for authorization from the Norwegian Directorate of Health. Additionally, you typically require a residence permit, unless you’re an EU/EEA/EFTA citizen, in which case registration with the police suffices. Proficiency in the Norwegian language is often necessary for pharmacy work in Norway, and pharmacists from non-EU/EEC countries may need to complete national courses and pass relevant tests. It is one of the highest-paying countries for pharmacists in Europe

10. Belgium

Average Salary: $91,219

Belgium is home to renowned pharmaceutical companies like UCB S.A, Janssen Pharmaceutica, and GSK plc (NYSE:GSK) that provide ample job opportunities. Belgium’s central location in Europe also benefits its role in the pharmaceutical sector. Belgium is one of the highest-paying countries for data scientists

9. New Zealand

Average Salary: $91,458

To become a pharmacist in New Zealand, one has to complete a Bachelor of Pharmacy from a recognized university like the University of Auckland or the University of Otago, followed by a one-year internship in a hospital or community pharmacy. The next step is to register with the Pharmacy Council of New Zealand to practice as a licensed pharmacist. New Zealand is one of the highest-paying countries for pharmacists. 

8. Canada

Average Salary: $98,742

To become a licensed pharmacist in Canada, you need a pharmacy degree from a Canadian university, pass the PEBC national board examination (except in Québec), and gain practical experience through an internship, all the while demonstrating fluency in English or French. Licensing is regulated provincially, and international pharmacy graduates have specific pathways through programs like the International Pharmacy Graduate Program and the International Pharmacy Bridging Program. It is a country with a high demand for pharmacists as well as the best country for pharmacist immigration

7. Australia

Average Salary: $99,174

To become a registered pharmacist in Australia, individuals must complete an accredited university pharmacy degree with prerequisites in subjects like Biology and Chemistry. After graduation, students complete an intern training program and pass the Pharmacy Board of Australia’s registration exam to become eligible for general registration as pharmacists. International practitioners may also need to register and undergo further examination. Australia is one of the best countries for pharmacists to work for

6. United Arab Emirates (UAE)

Average Salary: 101,360

To become a pharmacist in Dubai, a minimum of two years of experience in a retail pharmacy, a diploma or degree in pharmacy, along passing the Dubai Health Authority (DHA) registration exam are necessary. Centers like the Pharma International Institute provide coaching for exams like DHA, MOH, KAPS, PEBC, HAAD, and Prometric. UAE is one of the highest paying countries for ESL teachers

Click here to see the 5 Highest Paying Countries for Pharmacists

Suggested Articles:

Disclosure: None. 15 Highest Paying Countries for Pharmacists is originally published on Insider Monkey.

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

  • It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
  • It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
  • It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

  • The AI infrastructure supercycle
  • The onshoring boom driven by Trump-era tariffs
  • A surge in U.S. LNG exports
  • And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…